The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
The Epidemiology, Management and Associated Conditions in Alopecia Areata in Czech Republic: A University-clinic-based Cross-sectional and Cohort Study
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- No phase declared
- Sponsor
- Faculty Hospital Kralovske Vinohrady
- Participants (registry)
- 123
- Start
- October 2021
- Primary completion
- October 2022
- Study completion
- December 2022
- Last registry update
- December 2024
- Countries
- Czechia
Conditions studied: Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Alopecia Areata (& Ophiasis), Alopecia Barbae, Alopecia Diffuse, Autoimmune Diseases, Autoimmune Hyperthyroidism, Autoimmune Hypothyroidism, Diabetes Mellitus, Type 1, Ulcerative Colitis, Inflammatory Bowel Diseases, Crohn Disease, Rheumatoid Arthritis, Down Syndrome, Atopic Dermatitis, Atopic Asthma, Atopic Rhinitis, Vitiligo, Psoriasis, Ankylosing Spondylitis, Multiple Sclerosis, Lupus Erythematosus, COVID-19 Pandemic, Vaccine Reaction, Infections, Anemia, Pernicious
Interventions: Exposure of interest
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.